CNBS

Amplify Seymour Cannabis ETF

Actively managed by cannabis investment professional Tim Seymour

Fund Details

Data as of: N/A
Ticker CNBS
Inception 7/23/2019
Primary Exchange NYSE Arca
CUSIP 032108854
Net Assets N/A
Shares Outstanding N/A
# of Holdings N/A
Fees & Expenses
Management Fee: N/A
Other Expenses: N/A
Total Annual Fund Operating Expenses: N/A
Less Fee Waiver/Reimbursement: N/A1
Net Expense Ratio: N/A

1The Fund’s investment adviser has contractually agreed to waive its advisory fees and/or assume as its own expense certain expenses otherwise payable by the Fund to the extent necessary to ensure that total annual fund operating expenses do not exceed 0.75% of average daily net assets until March 1, 2023.

Fund Characteristics

Weighted Avg. Market Cap N/A
Price-to-earnings N/A
Price-to-book N/A
Standard deviation N/A

Standard deviation measures how dispersed returns are around the average. A higher standard deviation indicates that returns are spread out over a larger range of values and thus, more volatile.

Index Details

Index Name EQM Lithium & Battery Technology Index
Index Ticker BATTIDX
Index Provider EQM Indexes
Weighting Methodology Modified market-cap
Rebalance Frequency Quarterly
Index Website eqmindexes.com

CNBS ETF Video

Signup to receive updates on

CNBS

Why Invest in CNBS?

  • Purity: 80% of the portfolio companies with 50% or more of their revenue from the cannabis and hemp ecosystem.
  • Active Management: allows the ETF to make timely decisions and assess opportunities and risks in this fast-developing space. Tim Seymour is an experienced investor and recognized voice in the cannabis sector.
  • Diversification: CNBS holds a basket of companies diversified by industry, market cap and business focus, which helps to mitigate single stock risk.

The Cannabis Recap

Audio Commentary by Tim Seymour (8/1/22)
Check out Tim’s latest articles and media appearances HERE

DON'T
MISS A
RECAP

Image: The Cannabis Recap Audio Commentary by Tim Seymour

Tim covers a full slate of topics in 3 key areas:

  • Markets (companies, earnings, M&A activity, performance)
  • Macro (state and federal legislative landscape)
  • Portfolio dynamics (CNBS)

Check out Tim’s latest articles and media appearances HERE

WHY INVEST IN CANNABIS-RELATED COMPANIES

  1. Consumer Demand - Worldwide consumer spending on legal cannabis was $21.3bil in 2020, up 48% (from $14.4bil) in 2019.¹
  2. Legalization - Currently legal in some form in 47 US states and 21 countries, with more anticipated to come.
  3. Medical Use - Over 100 naturally occurring compounds - cannabinoids - are found in the cannabis plant. Currently three FDA approved drugs exist that incorporate cannabis compounds; however, research into other use and application cases is dramatically increasing.

THE CNBS DIFFERENCE

  • Purity - 80% of the portfolio companies with 50% or more of their revenue from the cannabis and hemp ecosystem.
  • Portfolio Manager - CNBS is an actively managed portfolio which allows the ETF to adjust its holdings on a daily basis. Tim Seymour is the portfolio manager of CNBS. Tim has over 20 years of general investment experience and has been an early stage investor and recognized voice in the cannabis industry. He serves as a board member or in an advisory role for several private cannabis companies and provides regular commentary as a host on CNBC’s show Fast Money.
  • Legal Review - CNBS will only hold companies deemed to be abiding by the federal laws within the countries they operate.
  • Diversification - CNBS will hold a basket of companies diversified by industry, market cap and business focus, which helps to mitigate single stock risk.

¹ BDS Analytics, Arcview Market Research, 2021

Objective and Strategy

CNBS is an ETF investing in the fast-developing global cannabis industry. The Fund is managed by Tim Seymour, a recognized voice and experienced investor in the cannabis space.

NAV and Market Price

Data as of: N/A
Previous Day's NAV Previous Day's Market Price
Net Asset Value N/A Closing Price N/A
Daily Change N/A Daily Change N/A
% Daily Change N/A % Daily Change N/A
30-Day Median Bid/Ask Spread N/A Premium/Discount % N/A
Premium Discount History

Daily Price/NAV Performance

Data as of: N/A
 

Fund Holdings

Data as of: N/A
TOP 10 HOLDINGS

Fund holdings are subject to change at any time and should not be considered recommendations to buy or sell any security.

CNBS Portfolio Selection

CNBS invests at least 80% of its assets in securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem, across one of three classifications:

Tim Seymour has over 20 years of investment experience as a portfolio manager, allocator, and capital markets professional across multiple asset classes. Mr. Seymour has been an early stage investor in the cannabis industry and serves as a board member or in an advisory role for several private cannabis companies. In addition, Mr. Seymour is a frequent and long-time contributor on CNBC, including over a decade as co-host on the show “Fast Money.” Mr. Seymour is the founder and Chief Investment Officer of Seymour Asset Management (“SAM”).

Market Segments

Data as of: N/A

Region Allocation

Data as of: N/A

Market Capitalization

Data as of: N/A
LARGE CAP (> $10B): N/A
MID CAP ($2B - $10B): N/A
SMALL CAP ($300M - < $2B): N/A
MICRO CAP (<$300M): N/A

Fund holdings are subject to change at any time and should not be considered recommendations to buy or sell any security.

Performance

  CUMULATIVE (%) ANNUALIZED (%)
  1 Mo. 3 Mo. 6 Mo. YTD Since Inception
(7/23/19)
1 Yr. Since Inception
(7/23/19)
Month end as of TBD
Fund NAV N/A N/A N/A N/A N/A N/A N/A
Closing Price N/A N/A N/A N/A N/A N/A N/A
Quarter end as of TBD
Fund NAV N/A N/A N/A N/A N/A N/A N/A
Closing Price N/A N/A N/A N/A N/A N/A N/A

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Short-term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. Brokerage commissions will reduce returns.

Premium/Discount​

Data as of: N/A
 

The table and line graph are provided to show the frequency at which the closing price of the Fund was at a premium (above) or discount (below) to the Fund's daily net asset value ("NAV"). The table and line graph represent past performance and cannot be used to predict future results. Shareholders may pay more than NAV when buying Fund shares and receive less than an NAV when those shares are sold because shares are bought and sold at current market prices.

This is your Counts mockup

Calendar Year Calendar Year through
Days traded at premium N/A N/A
Days traded at net asset value N/A N/A
Days traded at discount N/A N/A

CNBS Distributions

EX-DATERECORD DATEPAYABLE DATEAMOUNT

2019

2020

2021

12/29/2112/30/2112/31/21$0.00016

Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV, and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.

The Fund is subject to management risk because it is an actively managed. Companies involved in the cannabis industry face competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments. Securities issued by non-U.S. companies present risks beyond those of securities of U.S. issuers.

Many of the companies in which the Fund will invest are engaged in other lines of business unrelated to cannabis and these lines of business could adversely affect their operating results. Cannabis is a Schedule I controlled substance under the Controlled Substances Act (“CSA”), meaning that it has a high potential for abuse, has no currently “accepted medical use” in the U.S., lacks accepted safety for use under medical supervision, and may not be prescribed, marketed or sold in the U.S. Small and/or mid-capitalization companies may be more vulnerable to adverse general market or economic developments, and their securities may be less liquid and may experience greater price volatility than larger, more established companies as a result of several factors, including limited trading volumes, products or financial resources, management inexperience and less publicly available information. The Fund is non-diversified, which can cause greater share price fluctuation.

Amplify Investments LLC is the Investment Adviser to the Fund, and Penserra Capital Management, LLC serves as the Investment Sub-Adviser.

Amplify ETFs are distributed by Foreside Fund Services, LLC.

Subscribe

Receive the latest news and insights from Amplify.
First Name*
Last Name*
Company Name
Email*
Please select the category that describes you best:*
Zip Code*
Country*

Glossary of Terms